Dixie Harris
Intermountain Healthcare
10 Papers
7 Citations
Dixie Harris is an academic researcher from Intermountain Healthcare. The author has contributed to research in topics: Medicine & Lung injury. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study.
Denitza P. Blagev,Denitza P. Blagev,Dixie Harris,Angela Dunn,David Guidry,Colin K. Grissom,Colin K. Grissom,Michael J. Lanspa +7 more
TL;DR: Lung injury associated with e-cigarettes or vaping remains a clinical diagnosis with symptoms that overlap infectious and other lung diseases and maintaining a high index of suspicion for this disease is important as work continues in understanding the cause or causes, optimal therapy, and long-term outcomes of these patients.
153
Diagnosing EVALI in the Time of COVID-19.
Sean J. Callahan,Sean J. Callahan,Dixie Harris,Dave S. Collingridge,David Guidry,Nathan C. Dean,Nathan C. Dean,Michael J. Lanspa,Denitza P. Blagev,Denitza P. Blagev +9 more
TL;DR: A case series of patients who have been diagnosed with EVALI since the start of the COVID-19 pandemic is reported and strategies for the diagnosis and treatment of patients with EValI in the time of CO VID-19 are provided.
39
Prospectively Assessed Long-Term Outcomes of Patients with E-cigarette or Vaping-associated Lung Injury (EVALI).
Denitza P. Blagev,Sean J. Callahan,Dixie Harris,David Collingridge,Ramona O. Hopkins,J. Eve,Lindsey J Waddoups,Valerie T. Aston,Samuel Brown,Michael J. Lanspa +9 more
- 09 May 2022
TL;DR: Patients with EVALI, despite their youth, commonly have significant long-term respiratory disability, cognitive impairment, symptoms of depression, anxiety, post-traumatic stress, and persistent vaping.
6
Identification and treatment of obstructive sleep apnea by a primary care team with a subset focus on chronic pain management.
TL;DR: Team based care management for participants taking prescription opioids, where STOP-Bang questionnaires were completed, were associated with an increase in the identification and treatment of OSA.
Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype
K Warren,Emily Beck,Sean J. Callahan,My N. Helms,Elizabeth A. Middleton,Sean D Maddock,Jason Carr,Dixie Harris,Denitza P. Blagev,Michael J. Lanspa,Samuel M. Brown,Robert Paine +11 more
TL;DR: In this article , the authors compared cell populations and inflammatory immune populations from bronchoalveolar lavage fluid in individuals with EVALI to e-cigarette users without respiratory disease and healthy controls.